SAGE NASDAQ
Sage Therapeutics, Inc.
1W: -0.9%
1M: -4.4%
3M: +19.1%
1Y: -19.7%
3Y: -74.8%
5Y: -81.6%
$8.68
Last traded 2025-07-31 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$70M
Revenue
-27.6% YoY
$-301M
Net Income
+32.4% YoY
$-289M
Free Cash Flow
+22.6% YoY
100.2%
Gross Margin
-170.5%
Op. Margin
-156.8%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-60.4%
ROA-53.8%
ROIC-1759.3%
Valuation
P/E-4.8
P/B1.5
EV/EBITDA-0.7
Leverage
Debt/Equity0.03
Current Ratio9.16
Interest Cov.0.0x
Quality Scores
Piotroski F3/9
Altman Z-5.04
Beneish M-0.98